Short- and mid-term intravascular ultrasound analysis of the new ENDEAVOR CR zotarolimus-eluting stent: Insights from the RESOLUTE trial

被引：0
|
作者：
Waseda, Katsuhisa [1 ]
Yamasaki, Masao [1 ]
Koizumi, Tomomi [1 ]
Ako, Junya [1 ]
Honda, Yasuhiro [1 ]
Meredith, Ian [2 ]
Worthley, Stephen [3 ]
Whitbourn, Robert J. [4 ]
Walters, Darren [5 ]
Fitzgerald, Peter J. [1 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
[2] Monash Med Ctr, Clayton, Vic 3168, Australia
[3] Royal Adelaide Hosp, Adelaide, SA 5000, Australia
[4] St Vincents Hosp, Melbourne, Vic, Australia
[5] Prince Charles Hosp, Brisbane, Qld 4032, Australia
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2007年 / 100卷 / 8A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：19L / 20L
页数：2
相关论文
共 50 条
  • [31] Clinical Outcome of New Zotarolimus-Eluting Stent in Complex Coronary Diseases: Result from a CRIBS Trial Substudy
    Rahman, Afzalur
    Ahman, Moinuddin
    Ahmed, Moshin
    Chaudhury, Habib
    Husnayen, S. A. M.
    Azam, Golan
    Islam, Nazmul
    Hoque, Sania
    Chowdhury, Anwarul Hoque
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (8A): : 71A - 71A
  • [32] Long-Term Clinical Outcomes From the Zotarolimus-Eluting Stent Program: Final 5-Year Pooled Results From the ENDEAVOR Program
    Kandzari, David E.
    Leon, Martin B.
    Meredith, Ian T.
    Wijns, William
    Fajadet, Jean
    Mouri, Laura
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B71 - B71
  • [33] Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial
    Jensen, Lisette Okkels
    Maeng, Michael
    Thayssen, Per
    Villadsen, Anton
    Krusell, Lars
    Botker, Hans Erik
    Pedersen, Knud Erik
    Aaroe, Jens
    Christiansen, Evald Hoej
    Vesterlund, Thomas
    Hansen, Knud Noerregaard
    Ravkilde, Jan
    Tilsted, Hans Henrik
    Lassen, Jens Flensted
    Thuesen, Leif
    EUROINTERVENTION, 2011, 7 (03) : 323 - 331
  • [34] VESSEL RESPONSE TO THE NOVEL POLYMER-FREE BIOFREEDOM STENT VERSUS CONVENTIONAL DURABLE POLYMER COATING STENT: SHORT- AND MID-TERM INTRAVASCULAR ULTRASOUND RESULTS FROM THE BIOFREEDOM FIRST-IN-MAN TRIAL
    Sakata, Kenji
    Kim, Byeong-Keuk
    Otake, Hiromasa
    Waseda, Katsuhisa
    Schuler, Gerhard C.
    Hauptmann, Karl E.
    Schofer, Joachim
    Yock, Paul G.
    Honda, Yasuhiro
    Grube, Eberhard
    Fitzgerald, Peter J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1758 - E1758
  • [35] Impact of polymer formulations on neointimal proliferation following zotarolimus-eluting stent with a different polymer: Results of a 3D intravascular ultrasound analysis
    Waseda, Katsuhisa
    Ako, Junya
    Yamasaki, Masao
    Koizumi, Tomomi
    Sakurai, Ryota
    Hongo, Yoichiro
    Koo, Bon-Kwon
    Honda, Yasuhim
    Meredith, Ian
    Worthley, Stephen
    Walters, Darren
    Whitbourn, Robert
    Fitzgerald, Peter J.
    CIRCULATION, 2007, 116 (16) : 615 - 616
  • [36] Long-Term Clinical and Economic Analysis of the Endeavor Zotarolimus-Eluting Stent Versus the Cypher Sirolimus-Eluting Stent 3-Year Results From the ENDEAVOR III Trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)
    Eisenstein, Eric L.
    Leon, Martin B.
    Kandzari, David E.
    Mauri, Laura
    Edwards, Rex
    Kong, David F.
    Cowper, Patricia A.
    Anstrom, Kevin J.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (12) : 1199 - 1207
  • [37] IMPACT OF SHORT- VERSUS LONG-TERM DAPT IN PATIENTS WITH DIABETES MELLITUS UNDERGOING PERCUTANEOUS INTERVENTION WITH ENDEAVOR ZOTAROLIMUS-ELUTING STENTS - A SUBANALYSIS OF THE LARGE, PROSPECTIVE, RANDOMIZED, MULTICENTER OPTIMIZE TRIAL
    Feres, Fausto
    Costa, Ricardo
    Bhatt, Deepak
    De Paula, Joao
    Botelho, Roberto
    Antonio Marin-Neto, J.
    Berti, Sergio
    Teixeirense, Pablo
    Padilha, Rone
    Sarmento-Leite, Rogerio
    Korman, Adrian
    Sanchez, Andres
    Chaves, Aurea
    Abizaid, Andrea
    Abizaid, Alexandre
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A1859 - A1859
  • [38] Angiographic Late Lumen Loss and Intima Hyperplasia After Sirolimus-Eluting and Zotarolimus-Eluting Stent Implantation in Diabetic Patients. The Diabetes and Drug-Eluting Stent (DiabeDES III) Intravascular Ultrasound and Angiography Trial
    Jensen, Lisette Okkels
    Maeng, Michael
    Thayssen, Per
    Villadsen, Anton
    Boetker, Hans Erik
    Krusell, Lars R.
    Pedersen, Knud Erik
    Aaroe, Jens
    Vesterlund, Thomas
    Hansen, Knud N.
    Ravkilde, Jan
    Lassen, Jens F.
    Madsen, Morten
    Tilsted, Hans H.
    Thuesen, Leif
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (6A): : 138D - 139D
  • [39] Late Safety and Efficacy of a Zotarolimus-Eluting Stent Compared with a Paclitaxel-Eluting Stent in Patients with De Novo Coronary Lesions: Three-Year Follow-up from the ENDEAVOR IV Trial
    Leon, Martin B.
    Mauri, Laura
    O'Shaughnessy, Charles
    Ovelie, Paul A.
    McLaurin, Brent T.
    Solomon, Stuart L.
    Ball, Michael
    Douglas, John S.
    Cutlip, Donald E.
    Kandzari, David E.
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (6A): : 150D - 150D
  • [40] Comparison of short-term clinical outcomes between Resolute Onyx zotarolimus-eluting stents and everolimus-eluting stent in patients with acute myocardial infarction: Results from the Korea Acute Myocardial infarction Registry (KAMIR)
    Kim, Yongcheol
    Oh, Sung Sik
    Jeong, Myung Ho
    Ahn, Youngkeun
    Kim, Ju Han
    Hong, Young Joon
    Sim, Doo Sun
    Kim, Min Chul
    Kim, Hyo-Soo
    Yun, Kyeong Ho
    Oh, Seok Kyu
    Kim, Chong Jin
    Cho, Myeong Chan
    CARDIOLOGY JOURNAL, 2019, 26 (05) : 469 - 476
12345